Dyne Therapeutics

Dyne Therapeutics

Dyne Therapeutics

Dyne Therapeutics is a new biotechnology company pioneering targeted therapies for patients with serious muscle diseases
Founded
2018
Raised
$165M
Follow us
Latest funding
$115,000,000
Venture capital - 2020
Atlas Venture MPM Capital Wellington Management Company +5
$50,000,000
Venture capital (Series A) - 2019
MPM Capital Forbion Capital Partners
Team Size
1–10
Employees
$115,000,000 Venture capital
FinSMEs

Dyne Therapeutics Raises $115M in Equity Financing